Hemodynamic Profile of Portopulmonary Hypertension

被引:11
作者
Feltracco, P. [1 ]
Serra, E. [1 ]
Brezzi, M. L. [1 ]
Milevoj, M. [1 ]
Rizzi, S. [1 ]
Furnari, M. [1 ]
Barbieri, S. [1 ]
Salvaterra, F. [1 ]
Ori, C. [1 ]
机构
[1] Univ Hosp Padua, Dept Pharmacol & Anesthesiol, Padua, Italy
关键词
PULMONARY ARTERIAL-HYPERTENSION; LIVER-TRANSPLANTATION; NITRIC-OXIDE; MANAGEMENT; PRESSURES; DIAGNOSIS; CIRRHOSIS;
D O I
10.1016/j.transproceed.2009.02.058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portopulmonary hypertension (PPHTN) refers to the development of pulmonary arterial hypertension in the setting of portal hypertension with or without chronic hepatic failure. This syndrome is characterized by marked alternations of pulmonary vascular tone and obstruction of pulmonary arterial blood flow. An increased pulmonary blood flow, which is a hallmark of the hyperdynamic circulation of cirrhotic patients, seems to be present in almost all patients who develop PPHTN. The elevations of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) along with the transpulmonary gradient (TPG) have been considered in diagnosing PPHTN. Only a high TPG reflects the severity of obstruction to pulmonary blood flow and differentiates an elevated PAP with concomitant elevated PVR from the situation where the increase in PAP is due only to the hyperdynamic flow and elevated volume. A considerable risk for cardiovascular death arises when PAP increases significantly; this may occur in rapidly evolving syndromes, in very advanced disease, or during a complicated liver transplantation. The distinction between PPHTN and elevated PAP in the context of a hyperdynamic state is of great importance; a PAP increase of hyperkinetic origin, as opposed to PPHTN, is apparently not associated with a high risk for adverse effects during and following liver transplantation.
引用
收藏
页码:1235 / 1239
页数:5
相关论文
共 26 条
[1]   Primary pulmonary hypertension and thyroid disease [J].
Arroliga, AC ;
Dweik, RA ;
Rafanan, AL .
CHEST, 2000, 118 (04) :1224-1224
[2]   Pulmonary hypertension associated with liver cirrhosis: An echocardiographic study [J].
Auletta, M ;
Oliviero, U ;
Iasiuolo, L ;
Scherillo, G ;
Antoniello, S .
ANGIOLOGY, 2000, 51 (12) :1013-1020
[3]   Portopulmonary hypertension - A tale of two circulations [J].
Budhiraja, R ;
Hassoun, PM .
CHEST, 2003, 123 (02) :562-576
[4]   Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients [J].
Castro, M ;
Krowka, MJ ;
Schroeder, DR ;
Beck, KC ;
Plevak, DJ ;
Rettke, SR ;
Cortese, DA ;
Wiesner, RH .
MAYO CLINIC PROCEEDINGS, 1996, 71 (06) :543-551
[5]   PULMONARY-HYPERTENSION COMPLICATING PORTAL-HYPERTENSION - FINDINGS ON CHEST RADIOGRAPHS [J].
CHAN, T ;
PALEVSKY, HI ;
MILLER, WT .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 151 (05) :909-914
[6]   Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study [J].
Colle, IO ;
Moreau, R ;
Godinho, E ;
Belghiti, J ;
Ettori, F ;
Cohen-Solal, A ;
Mal, H ;
Bernuau, J ;
Marty, J ;
Lebrec, D ;
Valla, D ;
Durand, F .
HEPATOLOGY, 2003, 37 (02) :401-409
[7]   Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension [J].
Findlay, JY ;
Harrison, BA ;
Plevak, DJ ;
Krowka, MJ .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (05) :381-387
[8]   REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].
GIAID, A ;
SALEH, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :214-221
[9]   Portopulmonary hypertension [J].
Golbin, Jason M. ;
Krowka, Michael J. .
CLINICS IN CHEST MEDICINE, 2007, 28 (01) :203-+
[10]   Pulmonary vascular abnormalities in cirrhosis [J].
Herve, Philippe ;
Le Pavec, Jerome ;
Sztrymf, Benjamin ;
Decante, Benoit ;
Savale, Laurent ;
Sitbon, Olivier .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2007, 21 (01) :141-159